Collaborations Pharmaceuticals

Google updated the Multitask Unified model its search algorithm to respond to the flood of misinformation on the web.

It’s surprisingly easy to turn a well-intended machine learning model to the dark side. In an experiment, Fabio Urbina and colleagues at Collaborations Pharmaceuticals, who had built a drug-discovery model to design useful compounds and avoid toxic ones, retrained it to generate poisons.

From language to vision models, deep neural networks are marked by improved performance, higher efficiency, and better generalizations. Yet, these systems are also marked by perpetuation of bias and injustice.

Google spent the past year training an AI-powered health care program using personal information from one of the largest hospital systems in the U.S. Patients had no idea — until last week.